Komipharm International Co., Ltd. manufactures and sells veterinary vaccines, veterinary pharmaceuticals and disinfectants, and bio-fertilizers internationally. It also develops anticancer drugs and pain-relieving agents, which include Kominox, an arsenic-based oral drug; and Panaphix, a non-narcotic cancer pain reliever, as well as provides clinical pathological experiment, test, and analysis services. The company was formerly known as Korea Microbiological Laboratories Co., Ltd. and changed its name to Komipharm International Co., Ltd. in September 2004. The company was founded in 1972 and is headquartered in Siheung, South Korea.
Frequently asked questions
What sector does Komipharm International Co. Ltd (041960) operate in?
Komipharm International Co. Ltd belongs to the Healthcare sector and operates in the Pharmaceuticals industry.
What is Komipharm International Co. Ltd (041960) current stock price?
As of the latest data, Komipharm International Co. Ltd stock price is ₩9,150, with a previous close of ₩9,030. Komipharm International Co. Ltd gained ₩120 in the last trading session, representing a 1.33% increase.
What is Komipharm International Co. Ltd (041960) current market capitalization?
Komipharm International Co. Ltd market cap is approximately 528.98 billion.
Does Komipharm International Co. Ltd (041960) pay dividends?
No. Komipharm International Co. Ltd does not pay a dividend.
What is Komipharm International Co. Ltd (041960) beta (volatility) score?
Komipharm International Co. Ltd has a beta of -0.094, indicating lower volatility than the overall market.
